Skip to main content

Table 2 The incidence of VTE in different types of ILD

From: Incidence and risk factors of venous thrombotic events in patients with interstitial lung disease during hospitalization

Characteristics

Total, n = 5009 (%)

IPF, n = 5210 (%)

NSIP, n = 407 (%)

CTD-ILD, n = 1576 (%)

COP, n = 534 (%)

HP, n = 250 (%)

ANCA-AV–ILD, n = 63 (%)

Others, n = 1669 (%)

VTE

129(2.6)

18(3.5)

10(2.5)

48(3.0)

13(2.4)

9(3.6)

5(7.9)

26(1.6)

Only PTE

34(0.7)

8(1.6)

5(1.2)

7(0.4)

1(0.2)

6(2.4)

2(3.2)

5(0.3)

Only DVT

80(1.6)

8(1.6)

2(0.5)

37(2.3)

9(1.7)

2(0.8)

2(3.2)

20(1.2)

Concomitant PTE and DVT

15(0.3)

2(0.4)

3(0.7)

4(0.3)

3(0.6)

1(0.4)

1(1.6)

1(0.1)

  1. ILD interstitial lung disease, IPF idiopathic pulmonary fibrosis, NSIP nonspecific interstitial pneumonia, CTD-ILD connective tissue disease-associated ILD, COP cryptogenic organized pneumonia, HP hypersensitivity pneumonitis, ANCA-AV-ILD Anti-Neutrophil Cytoplasmic Antibodies -associated vasculitis related ILD, VTE venous thromboembolism, PTE pulmonary thromboembolism, DVT deep vein thrombosis